Comparison of tumor end points showed a ~25% extension of PyMT Tnf−⁄− lifespan over Tnf+/+ (Fig 3c), whereas PyMT Timp3−⁄−Tnf−⁄− group exhibited intermediary survival. This evidence concerns the gene TNF and neoplasm.